Literature DB >> 17550852

Multiple myeloma primary cells show a highly rearranged unbalanced genome with amplifications and homozygous deletions irrespective of the presence of immunoglobulin-related chromosome translocations.

Cristina Largo1, Borja Saéz, Sara Alvarez, Javier Suela, Bibiana Ferreira, David Blesa, Felipe Prosper, M Jose Calasanz, Juan C Cigudosa.   

Abstract

BACKGROUND AND OBJECTIVES: Multiple myeloma (MM) is a malignant plasma cell neoplasia in which genetic studies have shown that genomic changes may affect almost all chromosomes, as shown by fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH). Our objective was the genomic characterization of CD 138 positive primary MM samples by means of a high resolution array CGH platform. DESIGN AND METHODS: For the first time, a high resolution array CGH with more than 40,000 probes, has been used to analyze 26 primary MM samples after the enrichment of CD138-positive plasma cells.
RESULTS: This approach identified copy number imbalances in all cases. Bioinformatics strategies were optimized to perform data analysis allowing the segregation of hyperdiploid and non-hyperdiploid cases by array CGH. Additional analysis showed that structural chromosome rearrangements were more frequently seen in hyperdiploid cases. We also identified the same Xq21 duplication in nearly 20% of the cases, which originated through unbalanced chromosome translocations. High level amplifications and homozygous deletions were recurrently observed in our series and involved genes with meaningful function in cancer biology. INTERPRETATION AND
CONCLUSIONS: High resolution array CGH allowed us to identify copy number changes in 100% of the primary MM samples. We segregated different MM subgroups based on their genomic profiles which made it possible to identify homozygous deletions and amplifications of great genetic relevance in MM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17550852     DOI: 10.3324/haematol.11052

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  11 in total

1.  Use of autocorrelation scanning in DNA copy number analysis.

Authors:  Liangcai Zhang; Li Zhang
Journal:  Bioinformatics       Date:  2013-09-16       Impact factor: 6.937

2.  Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma.

Authors:  L Yang; H Wang; S M Kornblau; D A Graber; N Zhang; J A Matthews; M Wang; D M Weber; S K Thomas; J J Shah; L Zhang; G Lu; M Zhao; R Muddasani; S-Y Yoo; K A Baggerly; R Z Orlowski
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

3.  Identification of unbalanced genome copy number abnormalities in patients with multiple myeloma by single-nucleotide polymorphism genotyping microarray analysis.

Authors:  Yuhei Kamada; Mamiko Sakata-Yanagimoto; Masashi Sanada; Aiko Sato-Otsubo; Terukazu Enami; Kazumi Suzukawa; Naoki Kurita; Hidekazu Nishikii; Yasuhisa Yokoyama; Yasushi Okoshi; Yuichi Hasegawa; Seishi Ogawa; Shigeru Chiba
Journal:  Int J Hematol       Date:  2012-09-13       Impact factor: 2.490

4.  Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma.

Authors:  W J Chng; M A Gertz; T-H Chung; S Van Wier; J J Keats; A Baker; P L Bergsagel; J Carpten; R Fonseca
Journal:  Leukemia       Date:  2010-03-11       Impact factor: 11.528

5.  Evaluation of 13q14 status in multiple myeloma by digital single nucleotide polymorphism technology.

Authors:  Katy Hanlon; Lorna W Harries; Sian Ellard; Claudius E Rudin
Journal:  J Mol Diagn       Date:  2009-07-30       Impact factor: 5.568

6.  Targeting the absence: homozygous DNA deletions as immutable signposts for cancer therapy.

Authors:  Alexander Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-10       Impact factor: 11.205

7.  Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities.

Authors:  Esteban Braggio; Ahmet Dogan; Jonathan J Keats; Wee J Chng; Gaofeng Huang; Julie M Matthews; Matthew J Maurer; Mark E Law; David S Bosler; Michael Barrett; Izidore S Lossos; Thomas E Witzig; Rafael Fonseca
Journal:  Mod Pathol       Date:  2012-02-03       Impact factor: 7.842

8.  Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience.

Authors:  Jan Smetana; Jan Frohlich; Romana Zaoralova; Vladimira Vallova; Henrieta Greslikova; Renata Kupska; Pavel Nemec; Aneta Mikulasova; Martina Almasi; Ludek Pour; Zdenek Adam; Viera Sandecka; Lenka Zahradová; Roman Hajek; Petr Kuglik
Journal:  Biomed Res Int       Date:  2014-06-02       Impact factor: 3.411

9.  CNARA: reliability assessment for genomic copy number profiles.

Authors:  Ni Ai; Haoyang Cai; Caius Solovan; Michael Baudis
Journal:  BMC Genomics       Date:  2016-10-12       Impact factor: 3.969

10.  Identification of novel pathogenic copy number aberrations in multiple myeloma: the Malaysian context.

Authors:  Pau Ni Ivyna Bong; Ching Ching Ng; Kah Yuen Lam; Puteri Jamilatul Noor Megat Baharuddin; Kian Meng Chang; Zubaidah Zakaria
Journal:  Mol Cytogenet       Date:  2014-04-01       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.